Joan B. L.
- Country
- Spain
- Department
- Servicio de Hematología
Research Overview
- Phase III Randomized Trial of Bortezomib, Melphalan, Prednisone, Lenalidomide, Dexamethasone, Carfilzomib, and Daratumumab in Elderly Patients with Newly Diagnosed Multiple Myeloma
- AN OPEN-LABEL, RANDOMIZED, PHASE 3 STUDY OF LINVOSELTAMAB (REGN5458; ANTI-BCMA X ANTI-CD3 BISPECIFIC ANTIBODY) VERSUS THE COMBINATION OF ELOTUZUMAB, POMALIDOMIDE, AND DEXAMETHASONE (EPd), IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (LINKER-MM3)
- Phase II Multicenter Study of Elranatamab Monotherapy in Relapsed/Refractory Multiple Myeloma Post-Three Drug Class Exposure
Data & Insights
Has run more than one trial at 82 of 218 partner sites.
Specializations
Multiple Myeloma Research
The investigator specializes in treating various stages of multiple myeloma, with particular emphasis on relapsed/refractory cases and newly diagnosed multiple myeloma (NDMM). Their work encompasses innovative therapeutic approaches using novel drug combinations and targeted treatments.
- Advanced Treatment Protocols
- Novel Drug Combinations
- Early-Stage Disease Management
Their expertise extends to managing smoldering multiple myeloma (SMM), focusing on early intervention strategies for high-risk patients.
Amyloidosis Studies
The investigator conducts research in Light Chain (AL) Amyloidosis, particularly focusing on advanced cases classified as Mayo Stage IV. Their work involves evaluating new therapeutic approaches combined with standard care protocols.
- Advanced Stage Management
- Innovative Treatment Approaches
- Long-term Care Strategies
Their research includes assessment of survival outcomes and treatment efficacy in complex cases.
Myelodysplastic Syndrome
The investigator's work includes studies in higher-risk Myelodysplastic Syndrome, with specific focus on RARA-positive adult patients. Their research explores combination therapies and novel treatment approaches for newly diagnosed cases.
- Treatment Response Assessment
- Targeted Therapeutic Approaches
- Disease Management Strategies
Their expertise includes evaluation of complete remission rates in various therapeutic combinations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.